Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
283 hedge funds and large institutions have $3.9B invested in Amedisys in 2019 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 106 increasing their positions, 104 reducing their positions, and 32 closing their positions.
11% more capital invested
Capital invested by funds: $3.51B → $3.9B (+$388M)
2.07% more ownership
Funds ownership: 90.56% → 92.63% (+2.1%)
2% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 104
1% less funds holding
Funds holding: 285 → 283 (-2)
3% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 32
44% less call options, than puts
Call options by funds: $23.8M | Put options by funds: $42.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$84.1M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$70.7M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$27.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$18.5M |
| 5 |
BlackRock
New York
|
+$16.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$36.4M |
| 2 |
APG Asset Management
Amsterdam,
Netherlands
|
-$24.6M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$21M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$13.8M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$12M |
AMED Hedge Fund Activity: Q3 2019 in Review
283 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2019, worth a combined $3.9B — up 11% from $3.51B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of AMED and 31 opened new positions — a net loss of 1 holder — while 104 trimmed existing stakes and 106 added.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $84.1M. The largest seller was Vanguard Group, cutting an estimated $36.4M.
- 283 institutional investors held Amedisys (AMED) as of Q3 2019, down from 285 in Q2 2019.
- Funds reported $3.9B of Amedisys stock for Q3 2019, up 11% quarter-over-quarter.
- 31 funds opened new Amedisys positions in Q3 2019 and 32 closed out, a net change of -1 holder.
- The largest Amedisys buyer in Q3 2019 was Acadian Asset Management, an estimated $84.1M added.
- The largest Amedisys seller in Q3 2019 was Vanguard Group, an estimated $36.4M sold.
Based on aggregated 13F filings for Q3 2019.